|Dato’ Iskandar Mizal Bin Mahmood|
Aged 51, Male, a Malaysian
Independent Non-Executive Director of GTB
DATE OF APPOINTMENT
Director - 16 May 2012
Dato’ Iskandar graduated from Boston University, USA in 1989 with a Bachelor of Science degree in Business Administration majoring in Accountancy.
He was the founding CEO and a member of the Board of Malaysian Biotechnology Corporation Sdn Bhd (BiotechCorp). BiotechCorp is the Malaysian Government’s professional agency spearheading the development of the country’s biotechnology industry. He was appointed as the CEO and member of the Board in May 2005. Dato’ Iskandar was also the Chairman of the Board of Malaysian Bio-XCell Sdn Bhd, a 60% subsidiary of BiotechCorp that is undertaking the development of a comprehensive biotechnology ecosystem located in Iskandar Malaysia, Johor with UEM Sunrise Berhad. Under his leadership, BiotechCorp has grown to be one of the leading biotechnology industry developmental organizations within the region.
Prior to his appointment to BiotechCorp, Dato’ Iskandar was the CEO and a member of the Board of MTDC, Malaysia’s integrated venture capital company, which was then 51% owned by Malaysia’s Sovereign Wealth Fund, Khazanah Nasional Berhad.
Dato’ Iskandar was the Managing Director and Chief Executive Officer of Manipal Education Malaysia Sdn Bhd (MEM) for approximately 2 years before his appointment as Group Chief Executive Officer of Pos Malaysia Berhad. Under his stewardship, MEM obtained a full university license to operate Manipal International University.
Dato’ Iskandar was the Group Chief Executive Officer of Pos Malaysia Berhad until his resignation on 4 February 2015.
He is the Chairman of Nomination Committee and a member of the Remuneration Committee in GTB.
He attended all 5 Board Meetings held during the financial year ended 31 December 2016.
Dato’ Iskandar does not have any family relationship with any director and/or major shareholder of GTB, nor any conflict of interest in any business arrangement involving the Company.